Liver Cancer
Copyright ©The Author(s) 2002.
World J Gastroenterol. Jun 15, 2002; 8(3): 469-475
Published online Jun 15, 2002. doi: 10.3748/wjg.v8.i3.469
Table 1 The effects of AFP on the cell cycle progression. Bel 7402 cells maintained in RPMI 1640 medium were respectively treated with either AFP (20 mg·L-1), anti-AFP (40 mg·L-1), AFP (20 mg·L-1) + anti-AFP (40 mg·L-1) or HSA (20 mg·L-1) for 24 hours. The effects of AFP on the cell cycle progression were analyzed by flow cytometry. The data represented the mean values of four independent experiments performed each in triplicate
GroupsG1 (%)S (%)G2 + M (%)
Control37.0 ± 3.042.7 ± 2.819.2 ± 1.8
AFP20.3 ± 1.6a68.0 ± 4.2a12.7 ± 1.3a
AFP + anti-AFP32.0 ± 2.148.8 ± 2.519.2 ± 1.3
anti-AFP34.61 ± 1.945.8 ± 2.519.6 ± 1.9
HSA36.9 ± 4.343.2 ± 2.619.9 ± 2.4